Recombinant ITGAL (Efalizumab Biosimilar) anticorps

N° du produit ABIN5581189

Détail du produit anti-ITGAL (Efalizumab Biosimilar) anticorps

Antigène: ITGAL (Efalizumab Biosimilar)

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp ITGAL (Efalizumab Biosimilar) est non-conjugé

Application: Flow Cytometry (FACS), Blocking Peptide (BP)

Fonction: Recombinant rabbit monoclonal antibody raised against human ITGAL.

Réactivité croisée: Humain

Immunogène: Original antibody is raised against a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.

Clone: Hu1124

Isotype: IgG

Information d'application

Indications d'application: Blocking
Flow Cytometry (1 μg/mL)
The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS, pH 7.2 (0.02 % Proclin 300).

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Détails sur ITGAL (Efalizumab Biosimilar)

Antigène: ITGAL (Efalizumab Biosimilar)

Abstract: ITGAL (Efalizumab Biosimilar) Produits

Synonymes: anticorps CD11A, anticorps LFA-1, anticorps LFA1A, anticorps integrin subunit alpha L, anticorps ITGAL

Classe de substances: Biosimilar

Sujet: Full Gene Name: integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1, alpha polypeptide)
Synonyms: CD11A,LFA-1,LFA1A

ID gène: 3683

UniProt: P20701